ABSTRACT Objectives: Assess body mass index (BMI) reduction through a multidisciplinary intervention with sibutramine in adolescents of military parents and examine characteristics and behavioral traits as predictors of successful weight loss. Methods: A prospective study where participants received sibutramine daily for 6 months. Adolescents ages 12 to 18 with BMI-for-age and sex greater than 95 percentile and good health were enrolled. Outcome variables are BMI, biochemical indices, and clinical measurements. Predictor variables are participant demographics, family history, lifestyle changes, and behavioral traits assessed with behavioral assessment for children. Results: One hundred participants were recruited with 81% completion. In those participants who completed the 6-month intervention, a mean participant BMI reduction of 3.1 kg/m 2 (-9.3%) ( p 0.001; 95% CI: -10.5% to -7.9%) was obtained with 79% successfully meeting the weight loss goal. Sibutramine dose was increased from 10 to 15 mg at 3 months for participant with 2.5% BMI reduction from baseline. Sibutramine dose at 3 months ( p 0.001) and participants perception of relationship with parents ( p = 0.05) were statistically significant predictors of successful weight loss ( 10% reduction in BMI). Conclusions: Sibutramine was effective at promoting minimum beneficial BMI reduction of 5% in adolescents with service-connected parents; however, increasing dosage at 3 months did not improve the likelihood of being successful.
INTRODUCTION
Obesity in the general population is an epidemic, and although the U.S. military has specific weight-for-height standards required for accession and advancement, it is not insulated from comparable increases in obesity prevalence. It is estimated that 1 out of every 10 active duty service members is obese. 1 Adult obesity is likely to increase given the upward trend in adolescent obesity. This trend is reflected in civilian applicants for enlisted military service, of which 90% are adolescents, where obesity increased from 2.8 to 6.8% from January 1993 to December 2006. 2, 3 Subanalysis of a sample of civilians ages 17 to 20 using the National Health and Nutrition Examination Surveys (NHANES) from 1988 to 1994 revealed 18% of males and 43% of females did not meet Army retention weight-for-height allowances. 4, 5 The 2007-2008 NHANES results indicated that 16.9% of U.S. children and adolescents (2-19 years) fell within the obese category at the 95th percentile on the body mass index (BMI)-for-age growth charts. 6, 7 One in 10 enlisted soldiers were children of service-connected parent(s) themselves, and a high prevalence of obese civilian adolescents not eligible for enlistment poses a significant problem for future military readiness. 8 An assertive weight management program should be advocated in this age group to prevent expansion of the obesity epidemic.
More aggressive weight loss interventions other than traditional calorie restriction, exercise promotion, and behavior therapy is needed given the rise in obesity-related comorbid conditions. 9, 10 Four studies to date have assessed the efficacy of the anorexic agent sibutramine, in adolescents after either a 6-or 12-month period with behavioral therapy resulting in few adverse events and an 8 to 10% BMI reduction. [11] [12] [13] [14] These studies may have limited generalizability to an adolescent cohort of service-connected parent(s) for whom a military lifestyle involves frequent moves, minimal social support, and recurrent deployments of family members, and may hinder successful weight loss intervention. 15, 16 The purpose of this study was to assess the effectiveness of a combined intervention that includes traditional behavioral therapy and nutrition counseling with pharmacotherapy to promote weight loss in this unique cohort. A secondary objective was to examine the relationship between certain demographic characteristics and behavioral traits as predictors of successful weight loss.
PATIENTS AND METHODS

Study Design
This was a 6-month prospective study where all participants initially received 10 mg of sibutramine daily. Minimum and optimal goals were set as a 5% and 10% BMI reduction, respectively, in 6 months; a change found to have beneficial effects on cardiovascular risk factors. 17, 18 Sibutramine was uptitrated to 15 mg if a 2.5% BMI reduction was not met at 3 months. Patient compliance was assessed by monitoring medication dispensation and pill count records at each medical appointment.
Patient Population
Participants, ages 12 to 18 years, were dependents of at least one service-connected parent. Recruitment occurred over a 10-month period in the San Antonio, Texas, area to include Lackland and Randolph Air Force Bases and Fort Sam Houston. Eligibility screening was performed on participants: physical exam, electrocardiogram, metabolic and lipid blood tests, pregnancy test, screening questionnaire, and two psychometric tests. The screening questionnaire was adapted from the American Medical Association's Assessment and Management of Adult Obesity to provide an in-depth assessment of the participant and their environment, obtain demographic information and weight history, and evaluate their readiness for weight loss. 19 Important subjective information about confounders such as participant's motivation level, expectations, support system, and previous weight loss attempts were documented. Two age-appropriate psychometric tests were used at baseline, interpreted and the results used by a trained psychologist during individual counseling sessions: Behavioral Assessment for Children, 2 nd edition (BASC-2), 20, 21 and Eating Disorder Inventory, 3 rd edition (EDI-3).
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Inclusion criteria included: BMI (kg/m 2 ) 95 th percentile for age and sex based on Centers for Disease Control and Prevention (CDC) growth charts7; maintenance of a stable body weight 3 months before screening; and good general health.
Exclusion criteria included: untreated hypertension; cardiovascular diseases; history of migraine or seizure disorder; stroke or mini-stroke; diabetes mellitus; major psychiatric or eating disorders; use of drugs or supplements during the past 6 months that have a significant impact on weight; weight loss or weight gain of 2 kg in the previous 3 months; prior use of sibutramine or current medications contraindicated with its use; smoking in the past 6months; use of alcohol currently or during the past 6 months; history of bleeding disorders; pulmonary hypertension; active gastrointestinal disorders; and pregnancy and lactation.
The study was approved by the Brooke Army Medical Center (BAMC) Institutional Review Board; written parental informed consent and participant assent were obtained. Participants were withdrawn if they failed to attend three or more medical appointments, withdrew their informed consent, presented with a severe adverse event, initiated a medication contraindicated with sibutramine, or became pregnant.
Behavioral Intervention
Participants met with a trained psychologist at BAMC or Wilford Hall Medical Center. Thirty minute behavioral modification sessions were conducted once a week for month 1, bimonthly for months 2 and 3, and monthly for months 4, 5, and 6. Each session included, but was not limited to, self-monitoring of eating habits, physical activity, stress management, stimulus control, problem solving, contingency management, cognitive restructuring, and social support. Subjects recorded their daily food intake, physical activity, computer and television time, all of which were reviewed with the provider. Support group meetings were held every month with both parents and participants. Topics included positive reinforcement techniques to encourage behavior change, awareness of unconscious modeling of behavior patterns that may sensitize or increase the reinforcing value of food, education on various weight issues, and group physical activities. Compliance was assessed as attendance at 9 out of 11 visits.
Nutrition Counseling
Participants attended a 1-hour small group counseling session with a registered dietitian twice during the 6 months. Topics included counseling on the food guide pyramid, 500-calorie deficit individualized meal plans, introduction to the "Traffic Light Diet," 23, 24 reducing calories from high-fat, high-sugar foods and sweetened beverages, and use of the nutrition food label to make healthier food choices. Supplemental dietary topics were provided at monthly support group meetings and included: hunger management, fad diets, increasing calorie expenditure, macronutrient education, fast food options, and other issues identified by the participants. Participants were instructed to engage in at least 30 minutes of moderateintensity physical activity on 5 or more days of the week (about 150 minutes/week).
Outcome Measure
The primary efficacy measure was percent change in initial BMI and was calculated monthly by dividing squared height in meters into the body weight in kilograms. Standing height was measured in duplicate to the nearest 0.1 cm using a stadiometer and averaged. Body weight was measured in duplicate using a calibrated electronic scale accurate to the nearest 0.1 kg and averaged. Successful weight loss, based on previous adolescent sibutramine study results, 11, 44 was defined as a 10% BMI reduction from baseline to the 6-month end-point.
Secondary outcome measures included changes in clinical and biochemical indices from baseline to end of the study: waist circumference measured at the ileac crest during minimal respiration; and standard assessment of blood pressure, pulse, fasting blood glucose, lipid panel, liver enzymes (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]), and thyroid-stimulating hormone (TSH).
Statistical Analysis
Mann-Whitney U and c 2 analysis were used to characterize descriptive statistics of the subjects and their households.
Percentages of participants were stratified based on percent BMI reduction previously established by Berkowitz et al. (2003) categorized as 5%, between 5% and 10%, between 10% and 15%, or 15%.
14 Paired Student's t-test was used to compare BMI, clinical, and biochemical changes baseline to the 6-month end-point. Clinical and biochemical indices were stratified based on the 10% BMI reduction cutoff for successful weight loss and compared using Student's t-test. Post hoc logistical regression was conducted to identify potential predictors of successful weight loss. From among four categories of obesity predictors (demographic characteristics, family history, and assessment for lifestyle change behavioral profile variable), six characteristics (dose at 3 months, age, relative overweight, importance of weight loss to the participant, relations with parent(s), and sense of inadequacy) were entered into the prediction model based on a two-tailed level of significance at p 0.1. All other statistical tests assumed a two-tailed level of significance at p 0.05 using SPSS version 16.0 (SPSS, Inc., Chicago, Illinois). Statistical support was provided by the BAMC Department of Clinical Investigations.
RESULTS
Cohort Characteristics
One hundred participants were screened, 95 were eligible and enrolled, and 77 completed the 6-month intervention. Of those who completed the study, 79% (n = 61) attained a 5% BMI reduction and 44% (n = 34) attained a 10% BMI reduction. Reasons for withdrawal included: lack of interest (n = 10), noncompliance (n = 5), taking medications contraindicated for subtramine (n = 2), and 1 adverse event.
At baseline, participants were predominately female (74%) of varied ethnicity, with a mean age of 14.7 ± 1.9 years, mean BMI of 34.9 ± 6.0 kg/m 2 , and a mean waist circumference of 110.9 ± 14.3 cm (Table I) . Twenty-three percent (n = 22; 55% male) of participants met metabolic syndrome criteria. 25 Stratification by gender and ethnicity revealed 55% of those with criteria for metabolic syndrome were male, 45% were non-Hispanic white, 18% were African American, and 23% were Hispanic. Table II depicts family demographics. Over half of the participants resided in a household with both parents present; of those residing in a single parent household, the biological mother was most frequently the sole parent. The majority of parents were Army, noncommissioned officers (between E4 Specialist to E9 Sergeant Major), were not deployed at the time of the study, and were perceived by participants as being overweight. Nearly all participants had a sibling, of which one-third were perceived as being overweight by the participants.
Family Demographics of Cohort
Primary Outcome: Percent Change in BMI The present study resulted in a mean participant BMI reduction of 9.3% from baseline over the 6-month intervention period (p 0.001; 95% CI: -10.5% to -7.9 %) (Fig. 1) . After month 3, no statistically significant change in BMI occurred (p = 0.33). The greatest proportion (35.1%) of participants had a 5 to 10% BMI reduction with 79% of participants meeting the 5% minimum BMI reduction and 44% meeting criteria for successful weight loss (Table III) . Stratification by gender shows a BMI decrease from baseline by both cohorts, but no difference in their rates of BMI decrease over 6 months (p = 0.74; data not shown). Similarly, no difference in BMI at 6 months stratified by age or gender was noted (age p = 0.23; gender p = 0.52; data not shown). Table III illustrates that participant's weight decreased from a mean of 95.3 ± 20.8 kg to 87.6 ± 19.3 kg, and waist circumference was reduced from 111 ± 14.3 cm to 100 ± 18.5 cm.
Reported adverse effects included headaches, dry mouth, and constipation. Severe menorrhagia was reported in one participant that began concomitantly with increase of sibutramine from 10 to 15 mg. This participant was subsequently withdrawn from the study. Only one participant had sibutramine withheld and then reinitiated 2 weeks later because of elevated blood pressure ( 140/85 mmHg).
Secondary Outcomes: Clinical and Biochemical Indices and Predictor Variable Assessments
There was no statistical difference between baseline values and those observed after 6 months of sibutramine treatment in biochemical or cardiovascular parameters except for pulse, with a mean increase of 4 beats/minute ( p = 0.01, Table III ).
Comparison of clinical and biochemical indices of successful ( 10% BMI decrease from baseline) and unsuccessful ( 10% BMI decrease from baseline) participants yielded no statistical difference. Multivariate stepwise regression using six characteristics (dose at 3 months, age, relative overweight, importance of weight loss to the participant, relations with parent(s), and sense of inadequacy) was included in the model for successful weight loss (Table IV) . Dosage of medication at 3 months ( p 0.001) and the perception of the importance of the participant to their family (relation with parents, p = 0.05) were the most significant independent predictors of successful weight loss.
DISCUSSION
The present study extends prior literature on behavioral therapy and sibutramine use in a cohort of military dependent adolescents and makes a contribution to our understanding of predictors in successful weight loss. In comparison to sibutramine efficacy studies done on nonmilitary associated adolescents, baseline characteristics were similar.
This study was designed to follow that of Berkowitz et al. 2003 and 2006 studies 11, 14 with the goal of assessing response in adolescents of service-connected parents to behavioral therapy plus sibutramine and eventually determine its efficacy in weight maintenance. The BMI change of -9.3% was similar to that reported by prior studies.
11-14 BMI, when stratified by gender after 6 months of intervention, did not result in different rates of BMI change between each time interval (p = 0.74). Both gender groups yielded significant BMI decrease after month 1 and each time thereafter compared with baseline (males p 0.001, females p 0.001). Males (55%) comprised the greatest proportion of participants who met criteria for metabolic syndrome, consistent with reported observations that males have a higher prevalence of metabolic syndrome than females (5.1% vs. 1.7%; p 0.0001). 26, 27 Future studies with a larger sample size may reveal a differential response in weight loss by this intervention between adolescent males and females, with and without criteria for metabolic syndrome.
Compliance was associated with a 5% absolute weight loss. In this study, dosage of medication (p 0.001) was a significant predictor of successful weight loss although the participant's perceived relationship to their parent(s) showed a significant association. There may have been a differential response to sibutramine in appetite suppression with "responders" only requiring 10 mg for maximal appetite suppression and thus a greater probability of successful weight (20.4) loss as compared to "nonresponders" where uptitration to 15 mg did not change their perception of appetite suppression. However, Halford et al. 28 found that 10 to 15 mg of sibutramine significantly reduced appetite and increased within-meal rate of satiety in obese middle-aged women while not affecting resting metabolic rate. This information may be clinically relevant as it appears that dose increase in this adolescent cohort does not correlate to higher yield weight loss, thus shifting the risk-to-benefit ratio in the opposite direction. Recently the Food and Drug Administration recommended sibutramine withdrawal from the market because of the increased risk for serious cardiovascular events based on the results of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial 29, 30 ; thus, future studies will need to incorporate other innovative means to promote weight loss without the use of sibutramine as a pharmacologic adjuvant. Recent research supports that some individuals may ignore physiological cues of hunger and fullness and eat for other reasons, such as emotional, social, or environmental cues, which might support why sibutramine was ineffective in a portion of the participants of this study. [31] [32] [33] Thirty-five other variables chosen to have some predictive value in obese adults were screened for inclusion into the regression model and included the following categories: demographics, family history, assessment for readiness for lifestyle changes, and behavioral profile 34 ; however, none maintained statistical significance after stepwise logistic regression analysis.
As previously reported by Berkowitz et al. (2003 and , 11, 14 a statistically significant decrease in levels of low density lipoprotein (LDL), very-low-density lipoprotein (vLDL), triglycerides, and elevation in high density lipoprotein (HDL) was expected, although no differences were observed in obesity associated biochemical indices even among those who achieved greater than 10% reduction in BMI. Compliance to dietary and physical activity recommendation can affect individual lipid panels; however, potential confounders such as ethnic composition may influence baseline lipid levels and lipoprotein metabolism inhibiting an expected improved response from weight loss. 35, 36 Attrition rates at the onset of recruitment were of concern because of the unique stressors for these adolescents in a military "environment." Several factors may have contributed to a rate comparable to other studies [11] [12] [13] [14] involving nonmilitary-associated adolescents that ranged from 15 to 25%. One in three participants reported their parents as active duty, a small percentage of them were deployed, and military occupational specialties of soldiers at these bases have relatively lower deployment rates as compared to other specialties; taken together, this may contribute to more stability within the military family. 37, 38 In retrospect, the initial assumptions of higher attrition rates and less robust response to weight loss intervention may be more accurately reflected in the recruitment of an adolescent cohort with all active duty parent(s) having a high deployment rate, or actively deployed.
Limitations to study design included poor recruitment of those families with significant social inadequacies or military stressors. These factors contribute to difficulty committing to a time intensive protocol further increasing attrition. The limitation of small sample size is associated with a relatively higher risk of a type II error; however, the primary outcome in percent BMI change in dependent adolescents of serviceconnected parents is consistent with those of previous studies. [11] [12] [13] [14] Ethnic diversity is an important confounder for weight loss as disparities in obesity, body weight perception, as well as weight management behavior are distinct among differing ethnicities 39, 40 ; however, the sample size was too small to adequately assess ethnicity as a subgroup. The exclusion criteria created a selection bias for "healthier" obese adolescents without serious comorbidities, and the predominantly female sample further limits study generalizability, differing from other studies using participants with preexisting cardiovascular conditions or diabetes. 29, 41 The position of the American Dietetic Association is that multidisciplinary adolescent weight management interventions are more effective when physical activity, diet, and behavior change are incorporated. 42 Future studies should identify innovative weight management interventions that focus on multidisciplinary influence as well as the inclusion of family and parental support. The effectiveness of the multidisciplinary treatment in sustaining weight loss 6-month postpharmacologic adjuvant provided in this study will be documented in a separate.
